The FDA has approved an expanded indication of the WaveWriter SCS systems for the treatment of chronic low back and leg pain – Boston Scientific
Boston Scientific Corporation announced that the FDA has approved an expanded indication of the WaveWriter SCS Systems for the treatment of chronic low back and leg pain in… read more.
